Details checkedClinical trial listing onlyCheckedregistry

Hearts for Hearing electric-acoustic stimulation study

Also known as: Combined Electric and Acoustic Hearing in Children and Adults, EAS technology, CI plus hearing aid fitting, NCT05923203

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Device

Modality

Cochlear/Auditory Implant

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Clinical cochlear implant sound-processor and hearing-aid fitting

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

United States

Population

pediatric, adult, cochlear-implant, hearing-aid-user, sensorineural, bilateral

Trial IDs

Mechanism

Recruiting NIH-supported study evaluating clinical fitting of FDA-approved electric-acoustic stimulation systems in cochlear implant users with residual low-frequency acoustic hearing.

Indications

Hearing Loss Sensorineural Hearing Loss

Notes

Corrected from an unwieldy intervention label into a Hearts for Hearing study-level record. The registry describes clinical use/fitting of FDA-approved EAS systems, not a new standalone product or manufacturer-sponsored pipeline device.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT05923203

Open

Key Events

2022-12-05

Hearts for Hearing EAS study started

2025-10-20

ClinicalTrials.gov posted latest recruiting update reviewed in this pass

Clinical Trials (1)